Medipal Holdings Corp ADR (MAHLY)

Currency in USD
16.48
0.00(0.00%)
Closed·

MAHLY Financial Summary

Key Ratios

P/E Ratio12.62
Price/Book0.82
Debt / Equity0%
Return on Equity6.9%
Dividend Yield0.00%
EBITDA74.03B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2016
31/03
2017
31/03
2018
31/03
2019
31/03
2020
31/03
2021
31/03
2022
31/03
2023
31/03
2024
31/03
2025
31/03
* In Millions of JPY (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 193.19%
Dividend Yield
-
Industry Median 2.83%
Annualised payout
-
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 13, 2025
EPS / Forecast
19.43 / --
Revenue / Forecast
864.16B / --
EPS Revisions
Last 90 days

FAQ

What were Medipal ADR's earnings for the latest quarter?

The Medipal ADR EPS (TTM) is 193.19. Medipal ADR reported sales of 864,156.00, net income of 4,041.00, and EPS of 19.43 for the latest quarter.

What was Medipal ADR's net income for the latest quarter?

Medipal ADR's net income for the latest quarter was 4,041.00.

How did Medipal ADR's performance compare year-over-year in the latest quarter?

The company's revenue moved from 982,500.00 in the previous quarter to 864,156.00 in the latest quarter, and net income moved from 14,511.00 to 4,041.00 compared to the previous quarter.

What is Medipal ADR's net profit margin on a TTM basis?

Medipal ADR's trailing twelve months (TTM) net profit margin is 1.10%.

How does Medipal ADR's debt to equity ratio compare to industry standards?

Medipal ADR's total debt-to-equity ratio is 0.00%.

What is Medipal ADR's return on investment on a TTM basis?

Medipal ADR's trailing twelve months (TTM) return on investment (ROI) is 6.90%.

What were Medipal ADR's total assets and liabilities in the latest quarter?

As of the latest quarter, Medipal ADR reported total assets of 1,824,984.00 million and total liabilities of 1,009,447.00 million.

How has Medipal ADR's total revenue grown this year?

Medipal ADR's total revenue was 982,500.00 in the previous quarter and 864,156.00 in the latest quarter.

What is Medipal ADR's gross margin on a TTM basis?

Medipal ADR's trailing twelve months (TTM) gross margin is 6.97%.

What was Medipal ADR's revenue per share for the latest quarter?

Medipal ADR's revenue per share for the latest quarter was 44.07.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.